¾­µä´úлͨ·¹ãɸPCRоƬ(Metabolomic Pathway Profiling PCR Array-1, MPP-1) Ñ¡È¡ÁË12Ìõ¾­µä´úлÏà¹Øͨ·ÖеÄ168¸ö½Úµã»ùÒò½øÐÐÕûºÏ¼ì²â¡£ÕâЩ´úлͨ·¸²¸ÇÁ˶¯Îïϸ°ûÄڴ󲿷ִúл;¾¶ÒÔ¼°µ÷¿Ø;¾¶¡£MPP-1оƬÊǼà¿Øϸ°ûºÍ×éÖ¯ÄÚ´úл±ä»¯¡¢Ñо¿Ö×ÁöÖرà³ÌºÍÎÖ²®¸ñЧӦ(Warberg effect) µÈ´úлÏà¹Øµ÷¿Ø»úÀíµÄ¾­µäÑо¿¹¤¾ß£¬Óë´úл×éѧÁªºÏʹÓû¹¿É½øÒ»²½ÌáÉýÊý¾Ý²ã´Î¡£MMP-1оƬ¿Éͨ¹ýÒ»´ÎʵÑéÍê³É¶àÌõͨ·½Úµã»ùÒòµÄ¼ì²â£¬²»½öÓÐÀûÓÚ¿ìËÙ·¢ÏÖʵÑéÑù±¾ÖйؼüµÄµ÷±äͨ·£¬¶øÇÒÓÐÖúÓÚÀí½âÕâЩͨ·¼äµÄ¸´ÔÓÍøÂçµ÷¿Ø¹Øϵ£¨cross-talk£©¡£Í¬Ê±£¬PCRоƬ½á¹û²»ÐèÒªÔÙ½øÐÐÑéÖ¤£¬¶ÔÓÚÑùÆ·¡¢Ê±¼ä¡¢¾­·ÑÒ²¸ü¼Ó½ÚÊ¡¡£

 

 

 

|   PCRоƬ¼ò½é

       MPP-1оƬÓÉ2ÕÅ96¿×оƬ×é³É£¬Ã¿ÕÅ96¿×оƬ°üº¬84¶ÔPCRÒýÎÕâЩÒýÎﶼÊǾ­¹ýÔ¤ÏÈÑéÖ¤µÄ°ü±»ÔÚÖ¸¶¨µÄ¿×°åÖУ¬Ã¿¿é°åÓÐ12¸ö·´Ó¦¿×°ü±»Á˲»Í¬ÀàÐ͵ĶÔÕÕ£¬ÓÃÒÔ¼ì²â´Ó·´×ªÂ¼µ½qPCRÕû¸ö¹ý³ÌµÄ·´Ó¦Ð§ÂÊ¡£Ð¾Æ¬Éè¼Æ£º´ÓAÅŵ½GÅŵÄ84¸ö¿×ÖÐÊÇ°ü±»ºÃµÄÌØÒìÐÔ»ùÒòÒýÎHÅÅÓÐ5¸ö¿´¼Ò»ùÒò£¬¿É×÷ΪarrayÊý¾Ý±ê×¼»¯¹ý³ÌÖÐÑùÆ·µÄÑôÐÔ¶ÔÕÕ¡£Ò»¸öGDC£º»ùÒò×éDNA¶ÔÕÕ£¬¿ÉÓÃÓÚ¼ì²âRT-PCR·´Ó¦ÌåϵÖÐÊÇ·ñÓлùÒò×éDNAÎÛȾ¡£3¸öRTC£ºspike-in·´×ªÂ¼¶ÔÕÕ£¬¿ÉÓÃÓÚ¼ì²âÄæת¼·´Ó¦µÄÖÊÁ¿¡£3¸öPTC£ºÑôÐÔPCR¶ÔÕÕ£¬Ö÷ÒªÓÃÓÚʵʱ¼à²âarray·´Ó¦°åµÄPCRÀ©ÔöЧÂÊ£¬´Ó¶ø¿ìËÙÆÀ¹ÀÊý¾ÝµÄÖÊÁ¿¡£

|   Í¨Â·£¨12Ìõ£©ºÍ»ùÒò£¨168¸ö£©

¡ñ   PI3K-AKT Signaling Pathway: AKT3£»BAD£»BCL2£»BCL2L1£»BCL2L11£»CCND1£»CDK2£»CDKN1A£»CDKN1B£»CHUK£»CSF1R£»EIF4EBP1£»FOXO3£»GSK3B£»IFNAR1£»IRS1£»ITGB1£»MAP2K1£»MDM2£»MTOR£»MYC£»NFKB1£»PDPK1£»PRKCA£»PTK2£»RPS6KB1£»STK11£»TP53£»TSC2

¡ñ   AMPK Signaling Pathway: ACACA£»ACACB£»ADRA1A£»AKT3£»CAB39£»CAMKK2£»EEF2K£»EIF4EBP1£»ELAVL1£»GYS1£»HMGCR£»HNF4A£»LIPE£»MLYCD£»MTOR£»PDPK1£»PFKFB1£»PPARGC1A£»PRKAG2£»RPS6KB1£»SLC2A4£»SREBF1£»STK11£»STRADB£»TSC1£»TSC2£»ULK1

¡ñ   Glucose Metabolism£ºALDOA£»FBP1£»G6PD£»GPI£»PFKL£»PGLS£»PGM2£»RBKS£»RPE£»RPIA£»TALDO1£»TKT

¡ñ   Insulin Signaling Pathway£ºACACA£»AKT3£»ARAF£»CBL£»EIF4EBP1£»FASN£»G6PC£»GCK£»GRB2£»GSK3B£»HRAS£»INS£»INSR£»IRS1£»MAP2K1£»MAPK1£»MTOR£»PDPK1£»PIK3CA£»PPP1CA£»PRKCI£»PTPN1£»PTPRF£»SLC2A4£»SORBS1£»SOS1£»SREBF1

¡ñ   Fatty Acid Metabolism£ºACAA2£»ACADL£»ACADM£»ACADSB£»ACOX1£»CPT1C£»CPT2£»ECHS1£»EHHADH£»HADHA

¡ñ   Adipogenesis£ºACACB£»ADIPOQ£»IRS1£»LEP£»PPARA£»RXRA£»TNF£»TNFRSF1A£»TNFRSF1B

¡ñ   PPAR Targets£ºADIPOQ£»ANGPTL4£»APOA1£»CD36£»CYP27A1£»CYP7A1£»FABP1£»FABP3£»FABP4£»FADS2£»ILK£»LPL£»NR1H3£»OLR1£»PLTP£»PPARA£»PPARD£»PPARG£»RXRA£»SCD£»SLC27A4£»UCP1

¡ñ   Amino Acid Metabolism£ºAGMAT£»ALDH18A1£»ALDH4A1£»AMD1£»AOC1£»GATM£»LAP3£»OAT£»ODC1£»PRODH2£»SRM

¡ñ   Hippo Signaling Pathway£ºAMOT£»CCN2£»FBXW11£»FRMD6£»LATS2£»MOB1A£»NF2£»PPP1CA£»PPP2CA£»SAV1£»SERPINE1£»SMAD2£»SMAD4£»SMAD7£»TP53BP2£»WTIP£»YAP1

¡ñ   Epithelial to Mesenchymal Transition£ºAKT3£»CTNNB1£»EGFR£»FGFR1£»FN1£»GSK3B£»ILK£»ITGA5£»ITGAV£»ITGB1£»MSN£»PTK2£»RAC1£»STAT3£»TGFB1

¡ñ   Cancer Drug Resistance£ºAKT3£»ATM£»BAX£»BCL2£»BCL2L1£»BRCA1£»CCND1£»CCNE1£»CDK2£»CDK4£»CDKN1A£»CDKN1B£»CDKN2A£»EGFR£»IGF1R£»MYC£»NFKB1£»PPARD£»RARA£»RB1£»RXRA£»TP53

¡ñ   Cancer Drug Targets£ºAKT3£»BCL2£»CDC25A£»CDK2£»CDK4£»EGFR£»GRB2£»HRAS£»HSP90AA1£»IGF1R£»KRAS£»MDM2£»MTOR£»NFKB1£»PDGFRA£»PDGFRB£»PIK3CA£»PRKCA£»RHOA£»TP53

| PCRоƬʵÑéÁ÷³Ì

¡ñ   RNAÖƱ¸´¿»¯²¢Öʼ죨²»·ûºÏÒªÇóµÄÐèÒªÖØÐÂÌṩÑùÆ·Ëͼ죩

¡ñ   RNA·´×ªÂ¼ÎªcDNA

¡ñ   ÅäÖ÷´Ó¦Ìåϵ·ÅÈë¹Ì¶¨ºÃ»ùÒòÌØÒìÐÔÒýÎïµÄ96¿×°å¸÷¿×ÖÐ

¡ñ   ½«°åÖÃÓÚPCRÒÇÖУ¬ÔËÐгÌÐò

¡ñ   ¼ÆËãÿ¸ö»ùÒòµÄÑ­»·ãÐÖµ(Ct)·ÖÎö

¡ñ   ³ö¾ßʵÑ鱨¸æ°üÀ¨ÊµÑé·½·¨¼°ÊµÊ±¶¨Á¿PCRоƬʵÑé½á¹û¼°Ïà¹Øͼ±í

|   ½á¹ûչʾ

|   PCRоƬ³£¼ûÎÊÌâ

Q1¡¢PCR оƬµÄÖÊÁ¿ÈçºÎ£¿

ʵÑéÖеÄÒýÎÊÔ¼Á£¬ÊµÑéÌõ¼þ£¬²Ù×÷Á÷³Ì¶¼¾­¹ýÑϸñµØÖʼì¡£

Q2¡¢PCR оƬΪʲôѡÓöà¸ö¿´¼Ò»ùÒòµÄ×÷Óã¿

Ñо¿·¢ÏÖ²¢²»ÊÇËùÓеĿ´¼Ò»ùÒòÔÚϸ°ûºÍ×éÖ¯µÄËùÓн׶ξùºã¶¨±í´ï£¬Èç¹ûֻѡÓÃ1-2¸ö¿´¼Ò»ùÒò×÷ΪÄڲΣ¬¿ÉÄÜ»áµÃµ½´íÎóµÄ¿Æѧ½áÂÛ¡£

Q3¡¢PCR оƬÊÇ·ñÐèÒª½øÐм¼ÊõÖظ´ÊµÑ飿

ÍƼöÉúÎïѧÖظ´£¬ÒòΪPCR ArrayµÄÖظ´ÐԷdz£ºÃ£¬ÎÞÐè¼¼ÊõÖظ´¡£

Q4¡¢PCRоƬʵÑéµÄRNA ÓÃÁ¿£¿

ÿ¿é96 ¿×°åÉÏÒ»¸öÑù±¾1000ng ×óÓÒµÄ×ÜRNA¡£

Q5¡¢PCR оƬÉϵĻùÒòÊÇÔõôѡÔñµÄ£¿

ÕâЩ±»Ñ¡ÖеĻùÒò±ØÐë¶ÔÓÚÏàÓ¦µÄÐźÅתµ¼Í¾¾¶Ï൱ÖØÒª£¬²¢ÇÒÊÇÔÚmRNA ˮƽÉϵ÷¿ØµÄ¡£Ñз¢ÈËÔ±¼°ÉúÎïÐÅϢѧ¿Æѧ¼Òͨ¹ýÔĶÁÒÑ·¢±íÎÄÏ×»ò¶à¸öÊý¾Ý¿âÀ´É¸Ñ¡Ïà¹ØµÄ»ùÒò£¬È»ºóÔÙÓÃÎı¾·¢¾òµÄ·½·¨½øÐÐУ¶Ô¡£